The official blog of the Lung Institute.

What is My Why? Michelle Lesser

14 Feb 2018
| Under Featured | Posted by | 0 Comments
What is My Why? Michelle Lesser

A featured series where Lung Institute employees tell their stories. #WhatIsMyWhy

I have been with the Lung Institute for three years. I truly believe in what we do, and I also have a passion for what we do. I am the community relations specialist and in my role, I act as a physician’s liaison going out and meeting with primary care physicians, pulmonologists, respiratory therapists and others.

Tampa Bay and Beyond

Our goal is to build a network of doctors who will refer patients to us. Right now, I work with doctors in the Tampa Bay area, while I also host monthly webinars where we reach out across the country and even have had attendees beyond our borders.

Specifically, I love what I do because I get to help people – our patients – strive for a better quality of life. I am one of the very fortunate people here who gets a chance to change things in the future for virtually every person I meet.

There’s nothing that really takes the place of that for me. I have great relationships with our providers and my patients. Being able to do public speaking events is one of my strengths. I’ve been face-to-face with patients who are truly grateful for our webinars and I love the chance to educate them on what we do.

Patient Comes First

When best practices like empathy, active listening, respect, transparency and patience are exercised, both a patient and a client can find themselves in a deep, caring and safe relationship.

It’s not only important to be a positive face for the Lung Institute but also to nurture the relationship with a patient and the community. It’s a slow process, but I’m certain – without a doubt – that this will continue to grow. I’m grateful for the opportunity to get out into the community and show them what we are all about.

Thank you again for the opportunity to help and educate our patients and our community, which, if you think about it, can be considered the whole world. We still have a long road ahead of us, but I love the challenge. Where we are at now is great, but the future is unlimited.


* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.